Vaccine against Ebola: Commission grants new market authorisations

Ebola vaccine

(Credit: Unsplash)

This article is brought to you in association with the European Commission.


Today, the European Commission adopted the decision granting marketing authorisations to the company Janssen, a Johnson & Johnson company, for a vaccine against Ebola. The authorisation was granted in one month, reducing the decision-making process timing in half, further demonstrating the Commission’s commitment in placing the protection of public health as a priority.

The new Ebola vaccine, which consists of two components, called Zabdeno and Mvabea, had been in development with the support of the Commission. This decision follows a recommendation from the European Medicines Agency (EMA), which has assessed the benefits and risks of the vaccine.

Stella Kyriakides, Commissioner in charge of Health and Food Safety, said: “This is the second Ebola vaccine that the Commission authorises in less than a year and confirms once again that the EU remains at the forefront of the global effort to save lives from this virus. We know very well from the coronavirus crisis that viruses do not respect borders – protecting the health of others protects the health of all.”

Mariya Gabriel, Commissioner in charge of Research, said: Today, we can be glad to have supported the development of the Ebola vaccine with EU funding, in partnership with the European pharmaceutical sector under the Innovative Medicines Initiative. The investment from the EU’s research programme Horizon 2020 into several Innovative Medicines Initiative Ebola projects is now bearing fruit. This demonstrates, yet again, the power of collaboration and European R&I leadership to tackle global health threats. “

As explained by EMA when it recommended the approval last February, the ability of the immune system to respond to the virus after vaccination with Zabdeno and Mvabea was studied in a total of 3,367 adults, adolescents and children who participated in five clinical studies conducted in Europe, Africa and the US.

The development of the vaccine is the result of rigorous work by several projects funded with just over €130 million through the Innovative Medicines Initiative (IMI), which is partly supported by the EU’s research and innovation programme, Horizon 2020. Following a comprehensive approach, the EBOVAC 1, 2 & 3, projects assessed the safety and tolerability of the Ebola vaccine regimen through clinical trials in Europe and Africa. The EBODAC project developed a communication strategy and tools to promote the acceptance and uptake of new Ebola vaccines. Finally, the EBOMAN project focused on accelerating the development and manufacture of the vaccine.

Background

The authorisation of a medicine under the centralised procedure is a two-stage process, involving the European Medicines Agency (EMA) and the Commission. EMA assesses the benefits and risks of medicines and makes recommendations to the Commission, which then takes a final legally binding decision on whether or not the medicine can be marketed in the EU.

This decision is issued normally within the legal deadline of 67 days of the scientific opinion of EMA (for Zabdeno and Mvabea the date was 28 May). This phase includes, among other things, the translation of the product guidelines in all EU languages and a consultation with Member States. In view of the public health interest, the Commission has accelerated this process and authorised the medicine in around a month, in other words reducing the time taken for the decision-making process in half.

The assessment report for the vaccines will be published on EMA’s website.

IMI funds large-scale collaborative research projects bringing together academic and industrial partners, as well as patients and other stakeholders.

In November 2014, IMI responded very rapidly to the West Africa outbreak of Ebola by allocating €280 million to a comprehensive call for proposals to tackle a wide range of challenges in Ebola research, including vaccines development, clinical trials, storage and transport, as well as diagnostics. The first projects under the IMI Ebola+ programme started as early as January 2015 and several focused on the development of the Janssen vaccine regimen. Since 2014, IMI has funded 12 projects on Ebola and related diseases with a total combined budget of over EUR 300 million.

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

I accidentally went viral on TikTok. I learned we failed our youngest generation.

“The Belt and Road Initiative aims to promote peace, development and stability”, Ambassador Zhang of the Chinese Mission to EU highlights from European Business Summit 2018

Our tourism system is broken – time to customize

Dozens of children at risk as clashes in Hudaydah near hospital – UNICEF

Can autonomous cars make traffic jams a thing of the past?

UN chief sends condolences to families of Malawi flood victims

Trade in fake Italian goods costs economy billions of euros

UN envoy ‘encouraged’ by latest talks on avoiding ‘worst-case scenario’ in Syria’s Idlib

5 things to know about the Western Balkans

Countries must make teaching profession more financially and intellectually attractive

Will Brexit shatter the EU or is it still too early to predict?

MEPs commend Ukraine‘s reform efforts and denounce Russian aggression

Budget MEPs approve €104.2 m in EU aid to Greece, Spain, France and Portugal

Containers at the port of Tokyo. (Copyright: European Union, 2016. Source: EC - Audiovisual Service. Photo: Haruyoshi Yamaguchi)

EU cuts fast-track free trade deals with Japan and Singapore and leads the trade scene

Telemedicine and the Brazilian reality

Don’t take African generosity towards refugees for granted, says UN refugee chief

Brexiteer May gets lip-service from Trump and Turkish promises from Erdogan

UNICEF delivers medical supplies to Gaza in wake of deadly protests

New York high school students are getting free water bottles to cut plastic waste

EU: All economic indicators in free fall

8 amazing facts to help you understand China today

Denmark plans ‘Silicon Valley’ on 9 artificial islands off Copenhagen

Deal on digitalisation of access to justice will benefit citizens

The 28 EU leaders show contempt for the European Elections results

First-ever EU defence industry fund to finance joint development of capabilities

Brexit negotiations: back to square one, tougher words, no good faith

Mario Draghi quizzed for last time by Economic and Monetary Affairs Committee

Antimicrobial resistance: how can an intersectoral approach between society and healthcare professionals be developed and applied?

EU Leaders’ meeting in Sofia: Completing a trusted Digital Single Market for the benefit of all

Who will secure Lithuania?

UN condemns Syrian ‘war on children’ as up to 30 reportedly killed in clashes

Number of MEPs to be reduced after EU elections in 2019

How cities are failing to be inclusive – and what they can do about it

Coronavirus: Commission welcomes Parliament’s quick green light for proposed new resources to protect lives and livelihoods

Thursday’s Daily Brief: Poverty report reveals ‘vast inequalities’, measles compounds DRC Ebola woes, Guterres visits Mozambique, Bangladesh update, freedom of expression online

Japan’s holiest shrine is pulled down and rebuilt every 20 years – on purpose

MasterCard at European Business Summit 2015: A focus on innovation will drive inclusive economic growth for Europe

Parliament toughens its position on banking union

Education critical to ensure future of forests, and reverse their destruction

Sustainable Development Goals: making the world a better place

“China is the only BRICS country to have either met or possibly slightly surpassed my expectations”, BRICS inventor Jim O’ Neil from Switzerland; the Sting reports live from World Economic Forum 2015 in Davos

The future of international election observation missions

EU-US resume trade negotiations under the spell of NSA surveillance

Ukraine: Temperatures plunge amid rising humanitarian needs

Russia must urgently step up fight against foreign bribery

Bayer’s cross at night (Copyright: Bayer AG)

The EU clears Bayer-Monsanto merger amid wide competition and environmental concerns

Bank resolutions to remain a politically influenced affair

Asymptomatic, pre-symptomatic, symptomatic: what is the difference?

This AI trash can is designed to stop you wasting food

To hope or doubt? The state of women’s progress in the world

EU, Canada and China co-host international meeting on climate cooperation and a sustainable economic recovery

‘Stand united against anti-Muslim hatred’ urges Guterres, after mosque shootings in New Zealand leave 49 dead

The ocean is teeming with microplastic – a million times more than we thought, suggests new research

UN commission agrees roadmap on ensuring women’s social protection, mobility, safety, and access to economic opportunities

South Africa’s economy in 5 charts

Four things the UN chief wants world leaders to know, at key COP24 climate conference opening

Betazone: The Beauty of Inclusion

5 ways to make your organization a great sustainability partner

“Move fast, build to last: Europe’s new generation” – op-ed by Ursula von der Leyen, President of the European Commission

Why we need a Paris Agreement for nature

More Stings?

Advertising

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s